Investment Firm
Overview
Santa Ana Bio is a biotechnology company focusing on precision immunology for autoimmune and inflammatory diseases.
Jun 13, 2024
Series B
Highlights
Location
Social
Participant Investors
4
Santa Ana Bio raised $125000000 on 2024-06-13 in Series B
Santa Ana Bio is a biotechnology company focusing on precision immunology for autoimmune and inflammatory diseases.
Company Funding History
3
Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
---|---|---|---|---|
Feb 28, 2023 | Series A - Santa Ana Bio | 3 | - | 43.0M |
Jun 13, 2024 | Series B - Santa Ana Bio | 4 | - | 125.0M |
Jun 01, 2021 | Venture Round - Santa Ana Bio | - | 8.0M |
Recent Activity
There is no recent news or activity for this profile.